SCHEMBL19082279

SCHEMBL19082279

c1cc(-c2c3ccccc3c(-c3cccc4ccccc34)c3ccccc23)cc(-c2cc3sc4ccc5ccccc5c4c3c3sc4ccccc4c23)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.34
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
PTPN1 P18031 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
LIMK1 P53667 1/20 0.31
CYP1A1 P04798 1/20 0.30
CYP1B1 Q16678 1/20 0.30
CHEK1 O14757 1/20 0.30
WEE1 P30291 1/20 0.30
F9 P00740 1/20 0.30
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
DUSP3 P51452 1/20 0.30
BLM P54132 1/20 0.30
PTPN5 P54829 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945710 0.92 ALOX5 (0.38) ALOX5NQO1NQO2PTPN1CA12
SCHEMBL19082313 0.91 ALOX5 (0.34) ALOX5NQO1NQO2PTPN1CYP1A1
SCHEMBL19082280 0.91 ALOX5 (0.34) ALOX5NQO1NQO2PTPN1LIMK1
SCHEMBL17945735 0.88 ALOX5 (0.39) ALOX5NQO1NQO2PTPN1CA12
SCHEMBL17945525 0.88 ALOX5 (0.38) ALOX5NQO1NQO2PTPN1CA12
SCHEMBL19077329 0.88 CHEK1 (0.33) ALOX5NQO1NQO2PTPN1CA12
SCHEMBL19077326 0.87 ALOX5 (0.39) ALOX5PTPN1LIMK1CYP1A1CYP1B1
SCHEMBL19109296 0.86 ALOX5 (0.40) ALOX5PTPN1CA12CA1CA2
SCHEMBL19082264 0.86 NQO1 (0.33) ALOX5NQO1NQO2PTPN1CYP1A1
SCHEMBL19077332 0.85 ALOX5 (0.39) ALOX5PTPN1LIMK1CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885NQO1 576/4885NQO2 2592/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885NQO1 576/4885NQO2 2592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.